Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 October 2025 | Story Tshepo Tsotetsi | Photo Supplied
John Bridger Prof Johan Coetzee Roland Rudd Fiat Lux
From left: John Bridger, Old Boys Association Central Committee Board member; Prof Johan Coetzee; and Roland Rudd, Headmaster of Saint Andrews School; at the St Andrews Speech Day awards ceremony on 16 October.

Prof Johan Coetzee, Head of the Department of Economics and Finance at the University of the Free State (UFS), has been named the recipient of the Fiat Lux Award – the highest honour bestowed by St Andrew’s School in Bloemfontein. 

The award, presented at the annual St Andrews Speech Day awards ceremony on Thursday 16 October, recognises Old Andreans (alumni of the school) who have made exceptional contributions to society through professional excellence and personal integrity.

 

A journey of values, excellence, and lifelong connection

Previous recipients of the Fiat Lux Award include notable figures such as former Nedcor CEO Richard Laubscher, palaeoanthropologist, Apartheid activist, and three-time Nobel Prize nominee Prof Phillip Tobias, former President of the American Chamber of Commerce in South Africa Roger Crawford, and Carte Blanche Executive Producer George Mazarakis.

Prof Coetzee, who matriculated from St Andrew’s in 1995, describes the recognition as deeply humbling. “It is difficult to put into words what this means to me. As an Old Boy of St Andrew’s, it puts the seal of approval on the career path I chose – one that started in the corridors of that school 38 years ago,” he says.

He recalls that his school years shaped both his outlook and his work ethic. “The school taught me the importance of teamwork and resilience. It made me realise early on that life is not all rosy, and that one must maintain a balanced perspective – that is what sets St Andrew’s apart.”

For Prof Coetzee, this honour is not only a personal milestone but also a reflection of the close ties between the UFS and local schools of excellence. “It is extremely important for the UFS to maintain strong links with schools like St Andrew’s, which acts as a feeder for future students and athletes. It’s a win-win situation for both institutions,” he says.

He hopes that his recognition will inspire current learners at St Andrew’s to pursue their goals with perseverance. “I hope that this award awakens the drive in the current crop of pupils at Saints to realise that anything is possible – that your background or the setbacks you face do not define you. Also, and perhaps more importantly, that hard work and persistence does pay off.”

Prof Coetzee’s achievement reflects the UFS’ value of Excellence, exemplifying the university’s commitment to nurturing leaders who embody integrity, dedication, and a lifelong pursuit of learning.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept